30 Jun 2016
Eli Lilly & Co and Boehringer Ingelheim should be allowed to claim that their diabetes drug Jardiance, also known as empagliflozin, cuts the risk of cardiovascular death, conclude an advisory panel to the U.S. Food and Drug Administration.
Call for nominations for Awards Committee Chair
30 Oct 2024
James M Tanner Award - 2025 nominations open
30 Oct 2024
Would you like to host the BSPED annual meeting?
21 Oct 2024